Author:
Oliva Roberto,Ginestra Giovanna,Piperno Anna,Mazzaglia Antonino,Nostro Antonia,Scala Angela
Reference34 articles.
1. Abad, L., V. Tafani, V., Tasse, J., Josse, J., Chidiac, C., Lustig, S., Ferry, T., Diot, A., Laurent, F., Valour, F., 2019. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting. J. Antimicrob. Chemother. 74, 625–632. https://doi.org/10.1093/jac/dky473. PMID: 30517641.
2. Clinical update on linezolid in the treatment of Gram-positive bacterial infections;Ager;Infect. Drug Resist.,2012
3. Oxazolidinones: activity, mode of action, and mechanism of resistance;Bozdogan;Int. J. Antimicrob. Agents.,2004
4. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus: comparison with other drugs;Cafiso;FEMS Immunol. Med. Microbiol.,2010
5. Choudhary, A., Jain, P., Mohapatra, S., Mustafa, G., Ansari, M.J., Aldawsari, M.F., Alalaiwe, A,S., Mirza, M.A., Iqbal, Z., 2022. A novel approach of targeting linezolid nanoemulsion for the management of lymph node tuberculosis. ACS Omega. 25, 7(18):15688-15694. https://doi.org/10.1021/acsomega.2c00592.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献